160 related articles for article (PubMed ID: 36800277)
1. Mortality Not Increased in Patients With Nonfunctional Adrenal Adenomas: A Matched Cohort Study.
Kjellbom A; Lindgren O; Danielsson M; Olsen H; Löndahl M
J Clin Endocrinol Metab; 2023 Jul; 108(8):e536-e541. PubMed ID: 36800277
[TBL] [Abstract][Full Text] [Related]
2. Association Between Mortality and Levels of Autonomous Cortisol Secretion by Adrenal Incidentalomas : A Cohort Study.
Kjellbom A; Lindgren O; Puvaneswaralingam S; Löndahl M; Olsen H
Ann Intern Med; 2021 Aug; 174(8):1041-1049. PubMed ID: 34029490
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study.
Deutschbein T; Reimondo G; Di Dalmazi G; Bancos I; Patrova J; Vassiliadi DA; Nekić AB; Debono M; Lardo P; Ceccato F; Petramala L; Prete A; Chiodini I; Ivović M; Pazaitou-Panayiotou K; Alexandraki KI; Hanzu FA; Loli P; Yener S; Langton K; Spyroglou A; Kocjan T; Zacharieva S; Valdés N; Ambroziak U; Suzuki M; Detomas M; Puglisi S; Tucci L; Delivanis DA; Margaritopoulos D; Dusek T; Maggio R; Scaroni C; Concistrè A; Ronchi CL; Altieri B; Mosconi C; Diamantopoulos A; Iñiguez-Ariza NM; Vicennati V; Pia A; Kroiss M; Kaltsas G; Chrisoulidou A; Marina LV; Morelli V; Arlt W; Letizia C; Boscaro M; Stigliano A; Kastelan D; Tsagarakis S; Athimulam S; Pagotto U; Maeder U; Falhammar H; Newell-Price J; Terzolo M; Fassnacht M
Lancet Diabetes Endocrinol; 2022 Jul; 10(7):499-508. PubMed ID: 35533704
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Risk Markers in Adults With Adrenal Incidentaloma and Mild Autonomous Cortisol Secretion.
Chen AX; Radhakutty A; Drake SM; Kiu A; Thompson CH; Burt MG
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1020-e1028. PubMed ID: 37967229
[TBL] [Abstract][Full Text] [Related]
5. Mortality in Patients With Nonfunctional Adrenal Tumors.
Patrova J; Mannheimer B; Lindh JD; Falhammar H
JAMA Intern Med; 2023 Aug; 183(8):832-838. PubMed ID: 37358871
[TBL] [Abstract][Full Text] [Related]
6. Associations of age, BMI, and renal function to cortisol after dexamethasone suppression in patients with adrenal incidentalomas.
Olsen H; Olsen M
Front Endocrinol (Lausanne); 2022; 13():1055298. PubMed ID: 36760812
[TBL] [Abstract][Full Text] [Related]
7. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Pelsma I; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
Eur J Endocrinol; 2023 Jul; 189(1):G1-G42. PubMed ID: 37318239
[TBL] [Abstract][Full Text] [Related]
8. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
9. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
10. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
[TBL] [Abstract][Full Text] [Related]
11. Clinical course of patients with adrenal incidentalomas and cortisol autonomy: a German retrospective single center cohort study.
Remde H; Kranz S; Morell SM; Altieri B; Kroiss M; Detomas M; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2023; 14():1123132. PubMed ID: 37223045
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis.
Pelsma ICM; Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
Eur J Endocrinol; 2023 Oct; 189(4):S88-S101. PubMed ID: 37801655
[TBL] [Abstract][Full Text] [Related]
13. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
14. Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas.
Debono M; Bradburn M; Bull M; Harrison B; Ross RJ; Newell-Price J
J Clin Endocrinol Metab; 2014 Dec; 99(12):4462-70. PubMed ID: 25238207
[TBL] [Abstract][Full Text] [Related]
15. ACTH following overnight dexamethasone suppression can be used in the verification of autonomous cortisol secretion in patients with adrenal incidentalomas.
Puvaneswaralingam S; Kjellbom A; Lindgren O; Löndahl M; Olsen H
Clin Endocrinol (Oxf); 2021 Feb; 94(2):168-175. PubMed ID: 33108675
[TBL] [Abstract][Full Text] [Related]
16. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patients with adrenal incidentalomas.
Tsagarakis S; Roboti C; Kokkoris P; Vasiliou V; Alevizaki C; Thalassinos N
Clin Endocrinol (Oxf); 1998 Aug; 49(2):165-71. PubMed ID: 9828902
[TBL] [Abstract][Full Text] [Related]
17. Cortisol secretion from adrenal adenomas discovered as incidentalomas is responsive to ACTH.
Olsen H; Olofsson L; Mjöman M
Clin Endocrinol (Oxf); 2014 Mar; 80(3):335-41. PubMed ID: 23865937
[TBL] [Abstract][Full Text] [Related]
18. Discriminative Capacity of CT Volumetry to Identify Autonomous Cortisol Secretion in Incidental Adrenal Adenomas.
Olmos R; Mertens N; Vaidya A; Uslar T; Fernandez P; Guarda FJ; Zúñiga Á; San Francisco I; Huete A; Baudrand R
J Clin Endocrinol Metab; 2022 Apr; 107(5):e1946-e1953. PubMed ID: 35020922
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow-up.
Ruiz A; Michalopoulou T; Megia A; Näf S; Simón-Muela I; Solano E; Martínez L; Vendrell J
Eur J Clin Invest; 2019 Feb; 49(2):e13048. PubMed ID: 30412278
[TBL] [Abstract][Full Text] [Related]
20. Steroidogenesis in patients with adrenal incidentalomas: Extended steroid profile measured by liquid chromatography-mass spectrometry after ACTH stimulation and dexamethasone suppression.
Huayllas MKP; Smith LM; Gallagher JC; Netzel BC; Singh RJ; Kater CE
Clin Endocrinol (Oxf); 2021 Jul; 95(1):29-40. PubMed ID: 33598999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
